*ST恆康(002219.SZ):已有67家債權人申報了債權 申報金額合計約51.50億元
格隆匯9月6日丨*ST恆康(002219.SZ)公佈,依據《中華人民共和國企業破產法》等相關規定,債權登記、審查和其他相關工作管理人正在推進過程中。截至2021年9月6日上午12時,已有67家債權人向管理人申報了86筆債權,申報金額合計人民幣5,149,943,903.45 元。債權金額最終以法院裁定確認的債權表記載為準。恆康醫療重整案債權申報期限截止日為2021 年9 月6 日。
管理人於2021年8月31日與意向投資人北京新里程健康產業集團有限公司簽署《重整投資意向協議》。管理人於2021年9月3日在全國企業破產重整案件信息網發佈《關於公開招募和遴選重整投資人的公吿》。
恆康醫療集團股份有限公司重整案第一次債權人會議將於2021年9月16日上午9時30分通過網絡和現場會議的方式召開。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.